Cases & Deals

  • Home
  • Practices
  • GRA Venture Fund participates in $14 million Series A funding round of Micron Biochemical, Inc.

Share

GRA Venture Fund participates in $14 million Series A funding round of Micron Biochemical, Inc.

November 2022

Client(s) GRA Venture Fund, LLC

Jones Day represented GRA Venture Fund, LLC in connection with its participation in the $14 million Series A financing round of Micron Biochemical, Inc., a clinical stage life sciences company advancing its Micro Array Patch (MAP) technology for self-administration and simple, less-skilled caregiver administration of drugs and vaccines without needles.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.